Goldman Sachs Group Inc Applied Molecular Transport Inc. Transaction History

Goldman Sachs Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 14, 2024	SELL	$0.32 - $0.68 $3,616 - $7,686	-11,303 Reduced 48.74%	11,889 $3,000
Q1 2023 May 11, 2023	BUY	$0.32 - $0.68 $3,804 - $8,084	11,889 New	11,889 $3,000
Q3 2022 May 14, 2024	SELL	$1.12 - $3.12 $25,577 - $71,251	-22,837 Reduced 49.61%	23,192 $23,000
Q3 2022 Nov 10, 2022	SELL	$1.12 - $3.12 $25,577 - $71,251	-22,837 Reduced 49.61%	23,192 $0
Q2 2022 May 14, 2024	BUY	$2.76 - $7.65 $127,040 - $352,121	46,029 New	46,029 $134,000

Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $74,978 - $207,819	-27,166 Reduced 37.11%	46,029 $134,000
Q1 2022 May 16, 2022	SELL	$5.63 - $13.88 $322,311 - $794,616	-57,249 Reduced 43.89%	73,195 $550,000
Q4 2021 Feb 14, 2022	BUY	$13.23 - $26.05 $713,255 - $1.4 Million	53,912 Added 70.44%	130,444 $1.82 Million
Q3 2021 Nov 10, 2021	BUY	$25.87 - $46.61 $1.98 Million - $3.57 Million	76,532 New	76,532 $1.98 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.